Gene · 2237
Papers3,948
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,948
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Label-free and low-background FEN1 sensing based on cleavage-induced ligation of bifunctional dumbbell DNA and in-situ signal readout. | Spectrochim Acta A Mol Biomol Spectrosc | 2023 | 36603277 | PubTator, text mining | PubMed |
| Identification of probable inhibitors for the DNA polymerase of the Monkeypox virus through the virtual screening approach. | Int J Biol Macromol | 2023 | 36584781 | PubTator, text mining | PubMed |
| International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms. | Virchows Arch | 2023 | 36580136 | PubTator, text mining | PubMed |
| Green Closed-Loop Supply Chain Network Design During the Coronavirus (COVID-19) Pandemic: a Case Study in the Iranian Automotive Industry. | Environ Model Assess (Dordr) | 2023 | 36540109 | PubTator, text mining | PubMed |
| RNA-guided DNA base damage repair via DNA polymerase-mediated nick translation. | Nucleic Acids Res | 2023 | 36533524 | PubTator, text mining | PubMed |
| Cannabidiol-induced transcriptomic changes and cellular senescence in human Sertoli cells. | Toxicol Sci | 2023 | 36519830 | PubTator, text mining | PubMed |
Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established highrisk factors. | Haematologica | 2023 | 36519324 | PubTator, text mining | PubMed |
| Long non-coding RNA HOXC-AS1 exerts its oncogenic effects in esophageal squamous cell carcinoma by interaction with IGF2BP2 to stabilize SIRT1 expression. | J Clin Lab Anal | 2023 | 36510377 | PubTator, text mining | PubMed |
| A highly specific and flexible detection assay using collaborated actions of DNA-processing enzymes for identifying multiple gene expression signatures in breast cancer. | Analyst | 2023 | 36484412 | PubTator, text mining | PubMed |
| A scanning-to-incision switch in TFIIH-XPG induced by DNA damage licenses nucleotide excision repair. | Nucleic Acids Res | 2023 | 36477609 | PubTator, text mining | PubMed |
| Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients. | Leukemia | 2023 | 36470992 | PubTator, text mining | PubMed |
| Deep learning on multi-view sequential data: a survey. | Artif Intell Rev | 2023 | 36466765 | PubTator, text mining | PubMed |
| Double-wing switch nanodevice-mediated primer exchange reaction for the activity analysis of cancer biomarker FEN1. | Anal Chim Acta | 2023 | 36464437 | PubTator, text mining | PubMed |
| Impact of Asp/Glu-ADP-ribosylation on protein-protein interaction and protein function. | Proteomics | 2023 | 36453556 | PubTator, text mining | PubMed |
| Myelofibrosis progression grading based on type I and type III collagen and fibrillin 1 expression boosted by whole slide image analysis. | Histopathology | 2023 | 36416374 | PubTator, text mining | PubMed |
| Yeast 9-1-1 complex acts as a sliding clamp for DNA synthesis by DNA polymerase ε. | J Biol Chem | 2023 | 36410434 | PubTator, text mining | PubMed |
| Musculoskeletal radiologist-level performance by using deep learning for detection of scaphoid fractures on conventional multi-view radiographs of hand and wrist. | Eur Radiol | 2023 | 36380195 | PubTator, text mining | PubMed |
| Nuclear pCHK1 as a potential biomarker of increased sensitivity to ATR inhibition. | J Pathol | 2023 | 36373784 | PubTator, text mining | PubMed |
| Multimodal detection of flap endonuclease 1 activity through CRISPR/Cas12a trans-cleavage of single-strand DNA oligonucleotides. | Biosens Bioelectron | 2023 | 36368142 | PubTator, text mining | PubMed |
| Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study. | Br J Cancer | 2023 | 36323878 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2237/papers?page=30